The diagnosis and treatment of cellulitis is often complicated due to the presence different variants of cellulitis and pseudocellulitis. Dr. Kroshinsky describes how to differentiate between typical cellulitis and pseudocellulitis, using case studies derived from in-patient dermatology consults. In order to effectively treat cellulitis, this activity shows how to distinguish between different variants of cellulitis and pseudocellulitis conditions caused by neutrophilic diseases, inflammatory diseases and other conditions.
There have been many advances in the medical management of dermatologic disease. Office Dermatology will cover the diagnosis and management of common skin disorders and provide an update on therapeutics.
In this Clinical Coffee Break, Dr. Jacob Levitt reviews the different presentations of plaque psoriasis and compares the various therapy classes, including topical corticosteroids, conventional systemic therapies, and biologics. He also discusses how to select treatments based on symptom severity, and which treatments to avoid in special populations, such as pregnant women and those with renal insufficiency.
This talk will discuss commonly encountered oral erosions and ulcers. Diagnoses will include herpes simplex, erythema multiforme, oral erosive lichen planus, and pemphigus vulgaris. A handful of sexually transmitted diseases will also be covered, emphasizing clinical recognition of and first line treatments of syphilis, human papilloma virus, scabies, and molluscum. Finally, therapeutic updates in melanoma, psoriasis, and chronic idiopathic urticaria will be reviewed. Finally, antibody-based therapies for chronic idiopathic urticarial will be discussed.
Skin disease can be the first presenting sign of serious health problems. Early recognition and workup can often influence global patient outcomes. Using a case-based presentation, the cutaneous associations of important conditions will be reviewed. Attendees will learn to generate a differential for specific skin findings and increase their comfort in evaluating rashes. We will also review current diagnostic and treatment modalities.
Since their arrival, oral anti-fungal agents have been thought to induce liver disease. Often, these medications are avoided or used with caution and frequent laboratory testing. Join us in a discussion of a recent study that builds on previous work showing the risk of using these agents is extremely small.